Skip to main content
Andrew Place, MD, Pediatric Hematology & Oncology, Boston, MA

Andrew E Place MD PhD

Pediatric Hematologic Oncology


Co-Director, Hematologic Malignancy Program; Dana-Farber/Boston Children's Cancer and Blood Disorders Center Assistant Professor, Harvard Medical School

Join to View Full Profile
  • 450 Brookline AveDana 3-146Boston, MA 02115

  • Phone+1 617-632-2313

Dr. Place is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Andrew Place is a pediatric hematologist/oncologist in Boston, MA and is affiliated with multiple hospitals in the area, including Boston Children's Hospital, Dana-Farber Cancer Institute, and Brigham and Women's Hospital. He received his medical degree from Geisel School of Medicine at Dartmouth and has been in practice 11 years. He specializes in pediatric hematologic oncology and is experienced in developmental therapeutics and relapsed/refractory leukemia.

Education & Training

  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2009 - 2012
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2006 - 2009
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 2006
  • Dartmouth College
    Dartmouth CollegePhD, Pharmacology and Toxicology, 1998 - 2004

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • NH State Medical License
    NH State Medical License 2022 - 2026
  • RI State Medical License
    RI State Medical License 2022 - 2026
  • CT State Medical License
    CT State Medical License 2022 - 2025
  • MA State Medical License
    MA State Medical License 2009 - 2025
  • ME State Medical License
    ME State Medical License 2022 - 2025
  • VT State Medical License
    VT State Medical License 2023 - 2024
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Safety, Efficacy, and PK of the BCL2 Inhibitor Venetoclax in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid...
    Andrew E. Place, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Pediatric Clinical Malignant Hematology 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Dana-Farber/Boston Children's Ranked Among the Best Pediatric Cancer Programs in the Nation for 18th Year in a Row
    Dana-Farber/Boston Children's Ranked Among the Best Pediatric Cancer Programs in the Nation for 18th Year in a RowOctober 8th, 2024

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: